Sujay Kango, Chief Commercial Officer at INFINITY PHARMACEUTICALS, INC. (INFI), sold 149,702 shares at $1.30 ($191K) on 2016-12-12, disclosed to the SEC on 2016-12-14.
Open-market sale of $191k INFI by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.30 | 25,009 | $33K | 17.0% |
| 2 | $1.30 | 25,009 | $33K | 17.0% |
| 3 | $1.25 | 7,676 | $10K | 5.0% |
| 4 | $1.25 | 7,676 | $10K | 5.0% |
| 5 | $1.27 | 42,017 | $53K | 27.8% |
| 6 | $1.27 | 42,017 |
| $53K |
| 27.9% |
| 7 | $1.30 | 298 | $387 | 0.2% |
| Total | $1.28 avg | 149,702 | $191K | 100% |
| Filing → |
| XLRN | SELL | 2021-03-04 | $1.3M | — | Filing → |
| XLRN | SELL | 2021-01-06 | $2.5M | — | Filing → |
| XLRN | SELL | 2020-02-14 | $112K | — | Filing → |